Molecular Characterization of Candida Auris

Candida auris is emerging fungal opportunistic pathogen in developing countries. Much studies has been conducted on Candida albicans. there was a dire need to investigate this alarming threat. Our hypothesis is that by recording the patients diagnosed with oropharygneal candidiasis and collecting clinical swab samples from these patients will be fruitful if microbiological isolation, identification and molecular characterization will be done. So this is the first study on C. auris in south punjab, Pakistan. Aim of this study is to collect epidemiological data of C. auris.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Oral Fungal Infection Bacterial Infections and Mycoses Candidiasis Infections Mycoses

Age range

Up to 100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Bahawal Victoria Hospital Bahawalpur, Bahawalpur, Punjab Province, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Pre-diagnosed Patients of both gender from pre-selected localities

Exclusion criteria

Healthy individuals or individuals having no oral fungal infection individuals above 100 years of age

Treatment and study plan

No intervention

Other

Not required

Primary outcomes

Prevalence of C. auris

Time frame: From November 15, 2019 to February 29, 2020

patients from selected localities will be recorded along with total patients in that category, prevalence will be calculated on the record collected from specified duration of study
Seasonality of C. auris infection

Time frame: From November 15, 2019 to February 29, 2020

Number of patients recorded during different months will be the source of calculation of seasonality index of the C. auris infection
Drug susceptibility

Time frame: From November 15, 2019 to February 29, 2020

Antifungal drug discs will be used for assessing the antfungal drugs susceptibility

Sponsors and collaborators

Lead sponsor

Islamia University of Bahawalpur

Other

Registry information

Official study title

Formulation Development and In-Vitro Studies of Efficacy of Botanical Extracts Against Candida Auris

Acronym: OC

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Oct 10, 2019
Registry last updated: Oct 27, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed